Recent developments in Medicare include a new pilot program requiring prior approval for certain procedures, as initiated under the Trump administration. Six states are set to test this new Medicare model in 2026, aiming to implement prior authorization requirements, as outlined by the CMS. Additionally, concerns over profit-driven healthcare practices have been raised by Democrats, leading to significant criticism of the pilot program. In another development, some are questioning the effectiveness of new AI technologies in neurotechnology, suggesting that the industry may be in denial about the implications of these changes.